Skip to main navigation Skip to search Skip to main content

Corrigendum to “Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review”. [Vaccine X, 2024 Feb 23;18:100464] (Vaccine: X (2024) 18, (S2590136224000378), (10.1016/j.jvacx.2024.100464))

  • Hannah G. Davies*
  • , Emma V. Thorley
  • , Rossul Al-Bahadili
  • , Natalina Sutton
  • , Jessica Burt
  • , Lauren Hookham
  • , Kostas Karampatsas
  • , Philipp Lambach
  • , Flor Muñoz
  • , Clare L. Cutland
  • , Saad Omer
  • , Kirsty Le Doare
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The funding source was not appropriately acknowledged in the original article. The funding statement should have read as follows: “This project is part of the EDCTP2 programme (grant number RIA2018V-2304-PREPARE) supported by the European Union.”

Original languageEnglish
Article number100612
JournalVaccine: X
Volume23
DOIs
Publication statusPublished - Mar 2025
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2025 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review”. [Vaccine X, 2024 Feb 23;18:100464] (Vaccine: X (2024) 18, (S2590136224000378), (10.1016/j.jvacx.2024.100464))'. Together they form a unique fingerprint.

Cite this